PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 3 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Asiaticoside from C. erecta demonstrated in vivo antischistosomal activities against Schistosoma mansoni worms and in vitro apyrase inhibition [PMID: 35631657]
Evidence summary
PubMed sources
- 1.PMID: 20362037 (2010) — A new triterpene glycoside from Centella erecta. · Fitoterapia
- 2.PMID: 35631657 (2022) — Identification of Asiaticoside from Centella erecta (Apiaceae) as Potential Apyrase Inhibitor by UF-UHPLC-MS and Its In Vivo Antischistosomal Activity. · Pharmaceutics
- 3.PMID: 29209345 (2017) — Differentiation of Three Centella Species in Australia as Inferred from Morphological Characteristics, ISSR Molecular Fingerprinting and Phytochemical Composition. · Frontiers in plant science